GlassScriptPhysician profile
Raffi Calikyan
NPI 1417063603
$12,433.86
in general payments reported to CMS, 2019-2025
60 companies · $2,614 in 2025
The $2,614 reported for 2025 was more than what 81% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $659 · 2020: $858 · 2021: $1,673 · 2022: $1,952 · 2023: $2,137 · 2024: $2,542 · 2025: $2,614.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,292.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,292.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $2,899.20 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Astrazeneca Pharmaceuticals LP | $1,652.45 | 2019-2025 | Airsupra, Breztri, Tezspire |
| Mylan Specialty L.P. | $742.21 | 2019-2024 | Yupelri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $741.31 | 2019-2025 | Ofev, Spiriva Respimat, Stiolto Respimat |
| Genzyme Corporation | $726.20 | 2021-2025 | |
| Regeneron Healthcare Solutions, INC. | $584.28 | 2019-2025 | Dupixent |
| Vanda Pharmaceuticals INC. | $564.02 | 2021-2024 | Hetlioz, Fanapt |
| Pfizer INC. | $419.78 | 2020-2025 | |
| Abbvie INC. | $281.76 | 2021-2025 | Ubrelvy |
| Grifols USA, LLC | $228.43 | 2020-2025 | Prolastin-C Liquid |
| Lundbeck LLC | $227.82 | 2021-2025 | Rexulti |
| Exact Sciences Corporation | $218.02 | 2024-2025 | Cologuard Collection Kit |
| Janssen Pharmaceuticals, INC | $215.58 | 2020-2024 | Xarelto |
| Baxter Healthcare | $169.06 | 2024-2025 | Hillrom - Vest System Model 105 Home Care |
| Insmed, INC. | $162.36 | 2021-2025 | Arikayce |
Show all 60 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raffi Calikyan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.